Site News  |   Monitor Keywords  |   Monitor Archive  |   Organizer  |   Account Info  |

Electrically nonconductive occludent for tissue openings

Electrically nonconductive occludent for tissue openings description/claims

This application claims priority from Australian Provisional Patent Application No. 2005907188, entitled, “Improved Cochleostomy Sealing” which was filed on Dec. 21, 2005.

1. Field of the Invention

The present invention relates generally to cochlear implant devices, and more particularly, to an electrically nonconductive cochleostomy occludent.

2. Related Art

Hearing loss is generally of two types, namely conductive and sensorineural. The treatment of both of types of hearing loss has been quite different, relying on different principles to deliver sound signals to be perceived by the brain as sound. Conductive hearing loss occurs when the normal mechanical pathways for sound to reach the hair cells in the cochlea are impeded, for example, by damage to the ossicles. In such cases, hearing loss is often improved with the use of conventional hearing aids, which amplify the sound so that acoustic information reaches the cochlear hair cells. Such hearing aids utilize acoustic mechanical stimulation, whereby the sound is amplified according to a number of varying techniques, and delivered to the inner ear as mechanical energy. This may be through a column of air to the eardrum, or through direct delivery to the ossicles of the middle ear.

On the other hand, sensorineural hearing loss is due to the absence or destruction of the cochlear hair cells which are needed to transduce acoustic signals into auditory nerve impulses. Individuals suffering from this type of hearing loss are unable to derive any benefit from conventional hearing aid systems regardless of the volume of the acoustic stimulus. This is because the natural mechanisms for transducing sound energy into auditory nerve impulses are either absent or damaged. In such cases, cochlear™ implants (also referred to as cochlear™ devices, cochlear™ prostheses, cochlear™ implant systems, and the like; simply “cochlear implants” herein) have been developed to provide the sensation of hearing to such individuals. In cochlear implants, electrical stimulation is provided via stimulating electrodes positioned as close as possible to the nerve endings of the auditory nerve, essentially bypassing the hair cells in a normally functioning cochlea. The application of a stimulation pattern to the nerve endings causes impulses to be sent to the brain via the auditory nerve, resulting in the brain perceiving the impulses as sound.

The electrode array is inserted during an operation that usually takes between 2-3 hours depending on the device to be implanted. An incision is made behind the ear to expose the temporal bone; the temporal bone consists of the squamous, the mastoid, the tympanic, zygomatic and petrous segment. Typically, cochlear implants require the opening of the mastoid bone which leads to the middle ear. A shallow recess is then created to hold the implant package in place substantially level with the bone. Next a hole is drilled which allows the surgeon access into the cochlea. This hole is known as a cochleostomy—the opening from the middle ear to the perilymphatic canals of the cochlea. A cochleostomy may be formed through the round window 141, the oval window 110, the promontory or through the apical turn of the cochlea. The electrode array is then gently threaded into the shell-like structure of the cochlea and the incision closed; the cochleostomy remains open and heals with scar tissue over the next few days.

More recently various alternative approaches have been proposed to cause dynamic volume displacements of the perilymph, some of which require the implantation of an actuator that breaches the cochlea. These procedures require a cochleostomy or equivalent incision to provide the requisite access to the perilymphatic canals of the cochlea.

It is conventional during surgical implantation to use a tissue graft from the patient to provide a seal at the cochleostomy, primarily to reduce the risk of meningitis resulting from communication between the inner ear and the middle ear.

In one aspect of the invention, an electrically nonconductive occludent id disclosed, the occludent constructed and arranged to forcefully infill a tissue opening so as to effectively prevent transport of electrical current, fluid and bacteria through the tissue opening.

In another aspect of the invention, a cochlear implant is disclosed, the cochlear implant comprising: an elongate electrode carrier member having at least one electrode disposed thereon, wherein the carrier member is configured to traverse a cochleostomy to position the electrodes in the cochlea; and an electrically nonconductive occludent constructed and arranged to circumferentially surround a portion of the carrier member traversing the cochleostomy, and to forcefully infill cochleostomy thereby segregating perilymphatic canals of the cochlea from extracochlear regions.

In a further embodiment of the present invention, a method for implanting an elongate carrier member in a cochlea of a recipient is disclosed, the method comprising: creating a cochleostomy; implanting the carrier member into the cochlea; and positioning an electrically nonconductive occludent in the cochleostomy so as to cause the portion of the carrier member and the occludent to forcefully infill the cochleostomy.

An illustrative embodiment of the present invention will be described with reference to the accompanying figures, in which:

FIG. 1 is a perspective view of an example of an implanted cochlear implant suitable for implementing embodiments of the present invention;

FIG. 2A is a side view of an electrode assembly in accordance with one embodiment of the present invention;

FIG. 2B is a top view of the electrode assembly illustrated in FIG. 2A;

• Provisional Patent
• Utility Patent

• What Is a Patent?
• What Is a Trademark or Servicemark?
• What Is a Copyright?
• Patent Laws